Compare ARK Genomic Revolution ETF (ARKG) vs First Trust NASDAQ Cybersecurity ETF (CIBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs First Trust NASDAQ Cybersecurity ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while First Trust NASDAQ Cybersecurity ETF trades at $91.61. Which is the better fit depends on your goals.
| ARKG | CIBR | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $94.32 |
52-Week Low | $23.09 | $60.74 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CIBR trades at $91.88, down 2.52% today but maintains strong bullish momentum with 17 buy signals versus 5 sell signals. The cybersecurity ETF has significantly outperformed the S&P 500, delivering 22% returns since December 2025 compared to the index's 8%. Recent technical indicators show overbought conditions with RSI above 80, while moving averages remain strongly bullish. The fund benefits from growing cybersecurity spending exceeding $300 billion in 2026 and captures exposure to 30+ cybersecurity companies including CrowdStrike.
The outlook remains positive given structural growth in cybersecurity demand, though current overbought conditions suggest potential near-term consolidation. Key risks include concentrated tech exposure and valuation sensitivity. Institutional ownership continues to grow with recent filings showing significant position increases by wealth management firms, supporting the long-term investment case for digital defense exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →
